FDA expects to draft mifepristone safety review next year; pro-life groups call it ‘insufficient’ by Kate Scanlon 4:27 PM October 8, 2026 by Kate Scanlon 4:27 PM October 8, 2026 The Food and Drug Administration’s safety review of mifepristone is expected to stretch into next year, according to an Oct. 7 court filing, prompting disappointment from pro-life groups. FacebookTwitterEmail
